Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials

The objective of this study was to characterize isolates with reduced susceptibility to cefiderocol in patients receiving cefiderocol for nosocomial pneumonia or carbapenem-resistant infections in the Phase 3 APEKS-NP and CREDIBLE-CR studies. Susceptibility testing of isolates was conducted at a cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordmann, Patrice, Shields, Ryan K., Doi, Yohei, Takemura, Miki, Echols, Roger, Matsunaga, Yuko, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058874/
https://www.ncbi.nlm.nih.gov/pubmed/35076335
http://dx.doi.org/10.1089/mdr.2021.0180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058874/
https://www.ncbi.nlm.nih.gov/pubmed/35076335
http://dx.doi.org/10.1089/mdr.2021.0180

Ejemplares similares